Maturation and Phenotypic Heterogeneity of Human CD4+Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation

被引:10
作者
Matos, Tiago R. [1 ,2 ,3 ,4 ,5 ]
Hirakawa, Masahiro [1 ,2 ,3 ]
Alho, Ana C. [1 ,2 ,3 ,4 ]
Neleman, Lars [5 ]
Graca, Luis [4 ]
Ritz, Jerome [1 ,2 ,3 ]
机构
[1] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal
[5] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Dermatol, Amsterdam, Netherlands
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 11卷
关键词
Treg; regulatory T cell; immunology; T cell; heterogeneity; diversity; GvHD; alloHSCT; CD4; VERSUS-HOST-DISEASE; MASS CYTOMETRY; REGULATORY CELLS; CORD; MECHANISMS; COMPLEXITY; EXPRESSION; PROFILE; IMMUNE; NAIVE;
D O I
10.3389/fimmu.2020.570550
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) Regulatory T cells (Treg) play a critical role in maintaining immune homeostasis. Various Treg subsets have been identified, however the heterogeneity of Treg subpopulations during development remains uncharacterized. Using mass cytometry we obtained single cell data on expression of 35 functional markers to examine the heterogeneity of Treg cells at birth and in adults. Unsupervised clustering algorithms FlowSOM and ACCENSE were used to quantify Treg heterogeneity. As expected, Treg in umbilical cord blood were predominately naive while Treg in adult blood were predominately central memory and effector memory cells. Although umbilical cord blood Treg are mostly naive cells, we observed multiple phenotypic Treg subsets in cord blood. Nevertheless, peripheral blood in adults contained higher percentages of Treg and the heterogeneity of Treg was significantly increased in adults. We also studied Treg heterogeneity throughout a 2-year period after allogeneic hematopoietic stem cell transplantation (alloHSCT) and in patients with chronic graft-versus-host disease (cGVHD). Treg heterogeneity recovered rapidly after alloHSCT and gradually increased in the first two years post-transplant. However, patients with cGVHD had significantly fewer distinct Treg subpopulations, proposing a correlation between a disrupted Treg heterogeneity and cGVHD. Our study is the first to compare human Treg heterogeneity at birth, in healthy adults and in patients after alloHSCT with and without cGVHD. This approach to characterize Treg heterogeneity based on expression of a large panel of functional markers may enable future studies to identify specific Treg defects that contribute to immune dysfunction.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation
    Kawano, Yutaka
    Kim, Haesook T.
    Matsuoka, Ken-ichi
    Bascug, Gregory
    McDonough, Sean
    Ho, Vincent T.
    Cutler, Corey
    Koreth, John
    Alyea, Edwin P.
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    BLOOD, 2011, 118 (18) : 5021 - 5030
  • [42] T-cell frequencies of CD8+ γδ and CD27+ γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantation
    Gaballa, Ahmed
    Stikvoort, Arwen
    Onfelt, Bjorn
    Mattsson, Jonas
    Sundin, Mikael
    Watz, Emma
    Uhlin, Michael
    BONE MARROW TRANSPLANTATION, 2019, 54 (10) : 1562 - 1574
  • [43] Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation
    Patel, Sagar S.
    Rybicki, Lisa A.
    Corrigan, Donna
    Dumont, Carol
    Bolwell, Brian
    Dean, Robert
    Figueroa, Priscilla
    Hanna, Rabi
    Liu, Hien
    Gerds, Aaron T.
    Hill, Brian
    Jagadeesh, Deepa
    Kalaycio, Matt
    Pohlman, Brad
    Ricci, Kristin
    Sobecks, Ronald
    Lu, Wen
    Hamilton, Betty K.
    Majhail, Navneet S.
    BONE MARROW TRANSPLANTATION, 2019, 54 (05) : 775 - 781
  • [44] Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation
    Wolf, Dominik
    Wolf, Anna Maria
    Fong, Dominic
    Rumpold, Holger
    Strasak, Alexander
    Clausen, Johannes
    Nachbaur, David
    TRANSPLANTATION, 2007, 83 (08) : 1107 - 1113
  • [45] Allogeneic anti-CD19 CAR T cells: new perspectives in the treatment of B-cell malignancies that progress after allogeneic stem cell transplantation?
    Heiblig, Mael
    Salles, Gilles
    Thomas, Xavier
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S5 - S8
  • [46] Simultaneous Isolation of CD8+ and CD4+ T Cells Specific for Multiple Viruses for Broad Antiviral Immune Reconstitution After Allogeneic Stem Cell Transplantation
    Zandvliet, Maarten L.
    van Liempt, Ellis
    Jedema, Inge
    Kruithof, Simone
    Kester, Michel G. D.
    Guchelaar, Henk-Jan
    Falkenburg, J. H. Frederik
    Meij, Pauline
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (03) : 307 - 319
  • [47] T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia
    Bayegi, Shideh Namazi
    Hamidieh, Amir Ali
    Behfar, Maryam
    Saghazadeh, Amene
    Bozorgmehr, Mahmood
    Karamlou, Yalda
    Shekarabi, Mehdi
    Tajik, Nader
    Delbandi, Ali-Akbar
    Zavareh, Farzaneh Tofighi
    Delavari, Samaneh
    Rezaei, Nima
    TRANSPLANT IMMUNOLOGY, 2023, 77
  • [48] CD4+T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
    Takahashi, Hiroshi
    Ikeda, Kazuhiko
    Ogawa, Kazuei
    Saito, Syunnichi
    Ngoma, Alain M.
    Mashimo, Yumiko
    Ueda, Koki
    Furukawa, Miki
    Shichishima-Nakamura, Akiko
    Ohkawara, Hiroshi
    Nollet, Kenneth E.
    Ohto, Hitoshi
    Takeishi, Yasuchika
    BIOLOGICAL RESEARCH, 2015, 48
  • [49] A phase I study of CD25/regulatory T-cell-depleted donor lymphocyte infusion for relapse after allogeneic stem cell transplantation
    Nikiforow, Sarah
    Kim, Haesook T.
    Daley, Heather
    Reynolds, Carol
    Jones, Kyle Thomas
    Armand, Philippe
    Ho, Vincent T.
    Alyea, Edwin P., III
    Cutler, Corey S.
    Ritz, Jerome
    Antin, Joseph H.
    Soiffer, Robert J.
    Koreth, John
    HAEMATOLOGICA, 2016, 101 (10) : 1251 - 1259
  • [50] TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation
    Moatti, Audrey
    Debesset, Anais
    Pilon, Caroline
    Beldi-Ferchiou, Asma
    Leclerc, Mathieu
    Redjoul, Rabah
    Charlotte, Frederic
    Nhu Hanh To
    Bak, Adeline
    Belkacemi, Yazid
    Salomon, Benoit Laurent
    Issa, Fadi
    Michonneau, David
    Maury, Sebastien
    Cohen, Jose Laurent
    Thiolat, Allan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (04)